Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer
Rachel M Layman, Dafydd G Thomas, Kent A Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
Robert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
Plos One
|
March 28, 2015
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy
Craig J Galbán, Bing Ma, Dariya Malyarenko, et al.
Breast Cancer Research and Treatment
|
July 10, 2016
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer
Z A Nahleh, W E Barlow, D F Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2014
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500
Jeffrey B Smerage, William E Barlow, Gabriel N Hortobagyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2013
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors
Anne F Schott, Melissa D Landis, Gabriela Dontu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2017
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
N Lynn Henry, Joseph M Unger, Anne F Schott, et al.
Molecular Oncology
|
May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer
Costanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Science Translational Medicine
|
November 1, 2016
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Juwon Park, Robert W Wysocki, Zohreh Amoozgar, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2007
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer
Rachel M Layman, Dafydd G Thomas, Kent A Griffith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
Robert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
Plos One
|
March 28, 2015
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy
Craig J Galbán, Bing Ma, Dariya Malyarenko, et al.
Breast Cancer Research and Treatment
|
July 10, 2016
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer
Z A Nahleh, W E Barlow, D F Hayes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2014
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500
Jeffrey B Smerage, William E Barlow, Gabriel N Hortobagyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2013
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors
Anne F Schott, Melissa D Landis, Gabriela Dontu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2017
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
N Lynn Henry, Joseph M Unger, Anne F Schott, et al.
Molecular Oncology
|
May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer
Costanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Science Translational Medicine
|
November 1, 2016
Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
Juwon Park, Robert W Wysocki, Zohreh Amoozgar, et al.
Page
of 7